1.03  -0.11 (-9.65%)		07-26 16:00
Open: 1.14 High: 1.14 Volume: 2,137,868		Pre. Close: 1.14 Low: 1.01 Market Cap: 8(M)

Short term
Mid term
Targets	6-month :	9.11	1-year :	14.01
Resists	First :	7.8	Second :	12
Pivot price	2.27
Supports	First :	1	Second :	0.84
MAs	MA(5) :	1.98	MA(20) :	2.35
	MA(100) :	5.28	MA(250) :	29.27
MACD	MACD :	-0.7	Signal :	-0.7
%K %D	K(14,3) :	0.5	D(3) :	8
RSI	RSI(14): 40
52-week	High :	118.5	Low :	1

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ AZTR ] has closed above bottom band by 17.7%. Bollinger Bands are 48.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	1.14 - 1.15	1.15 - 1.16
Low:	0.99 - 1	1 - 1.01
Close:	1.02 - 1.03	1.03 - 1.04

Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.

Fri, 26 Jul 2024
Short Interest in Azitra, Inc. (NYSEAMERICAN:AZTR) Increases By 160.2% - Defense World

Thu, 25 Jul 2024
Azitra, Inc. Announces Closing of Public Offering - StockTitan

Wed, 24 Jul 2024
Why Azitra Stock Is Crashing - Benzinga

Wed, 24 Jul 2024
AZTR hits 52-week low, trading at 1.28 USD - Investing.com

Wed, 24 Jul 2024
Why Is Azitra (AZTR) Stock Down 75% Today? - InvestorPlace

Tue, 23 Jul 2024
Azitra, Inc. Announces Pricing of $10.0 Million Public Offering - StockTitan

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: AMEX
Sector: Healthcare
Industry: Biotechnology
Shares Out	12 (M)
Shares Float	3 (M)
Held by Insiders	7 (%)
Held by Institutions	56.5 (%)
Shares Short	4 (K)
Shares Short P.Month	3 (K)

EPS	-1.24
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0.43
Profit Margin	0 %
Operating Margin	-641.7 %
Return on Assets (ttm)	-57.5 %
Return on Equity (ttm)	-379.7 %
Qtrly Rev. Growth	540.5 %
Gross Profit (p.s.)	0.02
Sales Per Share	0.05
EBITDA (p.s.)	-0.63
Qtrly Earnings Growth	0 %
Operating Cash Flow	-7 (M)
Levered Free Cash Flow	-5 (M)

PE Ratio	-0.84
PEG Ratio	0
Price to Book value	2.34
Price to Sales	19.89
Price to Cash Flow	-1.8

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.